Cargando…
Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is the most common and among the deadliest of pancreatic cancers. Its 5-year survival is only ∼8%. Pancreatic cancers are a heterogeneous group of diseases, of which PDAC is particularly aggressive. Like many other cancers, PDAC also starts as a pre-invasive p...
Autores principales: | Mishra, Nitish Kumar, Southekal, Siddesh, Guda, Chittibabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659773/ https://www.ncbi.nlm.nih.gov/pubmed/31379917 http://dx.doi.org/10.3389/fgene.2019.00624 |
Ejemplares similares
-
Prognostic value of biomarkers in the tumor microenvironment of pancreatic ductal adenocarcinoma
por: Mishra, Nitish K., et al.
Publicado: (2020) -
Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles
por: Mishra, Nitish Kumar, et al.
Publicado: (2020) -
Pan-Cancer Analysis of Human Kinome Gene Expression and Promoter DNA Methylation Identifies Dark Kinase Biomarkers in Multiple Cancers
por: Southekal, Siddesh, et al.
Publicado: (2021) -
Molecular Subtyping and Survival Analysis of Osteosarcoma Reveals Prognostic Biomarkers and Key Canonical Pathways
por: Southekal, Siddesh, et al.
Publicado: (2023) -
mintRULS: Prediction of miRNA–mRNA Target Site Interactions Using Regularized Least Square Method
por: Shakyawar, Sushil, et al.
Publicado: (2022)